Health Catalyst (HCAT) Gains from Investment Securities (2018 - 2025)

Health Catalyst has reported Gains from Investment Securities for 8 years, with the latest figure at -$8.0 million in Q4 2025.

• For the quarter ending Q4 2025, Gains from Investment Securities changed N/A year-over-year to -$8.0 million; the trailing twelve-month figure through Dec 2025 stood at -$9.7 million (down 488.06% YoY), and the FY2025 full-year result was -$7.1 million, down 330.15% from the prior year.
• Gains from Investment Securities for Q4 2025 stood at -$8.0 million, down from -$1.6 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $13.7 million in Q3 2021, with the low at -$13.7 million in Q4 2021.
• Historically, Gains from Investment Securities has averaged -$1.2 million across 5 years, with a median of -$1.9 million in 2021.
• Annual changes were most pronounced in 2021 — Gains from Investment Securities soared 700.56% — and 2022, when it plunged 490.72%.
• Health Catalyst's Gains from Investment Securities stood at -$13.7 million in 2021, then soared by 64.58% to -$4.8 million in 2022, then soared by 142.03% to $2.0 million in 2023, then plunged by 180.77% to -$1.6 million in 2024, then plunged by 388.06% to -$8.0 million in 2025.
• The last three Gains from Investment Securities figures came in at -$8.0 million (Q4 2025), -$1.6 million (Q3 2024), and $2.0 million (Q2 2023), per Business Quant data.